· 51 min
Longevity Scientist: Aging Is A Disease. We Just Don’t Know How to Treat (yet)
Joe Betts-LaCroix and Retro Biosciences recently raised funding at a $1.8 billion valuation. In his first podcast appearance since the announcement, Joe shares his vision for extending healthy human lifespan and the breakthroughs driving the longevity industry forward.
Explore conversation


